Loading...
STERIMAX INC — Furosemide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #15 buyer for Furosemide · $622.7K import value · 14 shipments · CANADA · DGFT Verified
STERIMAX INC is the #15 importer of Furosemide from India with $622.7K in import value and 14 verified shipments. STERIMAX INC holds a 1.0% market share in Furosemide imports based in CANADA. The company sources from 1 verified supplier across 12 formulations shipped to 1 country. Overall, STERIMAX INC imports 3 pharmaceutical products worth $1.9M across 3 therapeutic categories.
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED | $622.7K | 14 | 100.0% |
STERIMAX INC sources Furosemide from 1 verified Indian supplier based on 14 customs records. The primary supplier is BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | EVERSANA | UNITED STATES | $1.0M | 20 | $50.0K |
| 18 | MINT PHARMACEUTICALS INC | CANADA | $750.0K | 15 | $50.0K |
| 15 | STERIMAX INC ★ | CANADA | $700.0K | 14 | $50.0K |
STERIMAX INC ranks #15 among 778 Furosemide importers from India. Average shipment value of $50.0K compared to the market average of $39.5K. The closest competitors by value are EVERSANA and MINT PHARMACEUTICALS INC.
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $622.7K | 14 | 100.0% |
STERIMAX INC imports Furosemide to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $622.7K.
| Formulation | Value | Shipments |
|---|---|---|
| FUROSEMIDE INJECTION USP (10MG/ML) 4 ML | $100.0K | 2 |
| FUROSEMIDE INJECTION USP (10MG/ML) 4 MLGLASS AMPOULE | $89.6K | 2 |
| FUROSEMIDE INJECTION USP (10 MG/ML) 4ML | $50.0K | 1 |
| FUROSEMIDE INJECTION USP(10MG/ML) 4 ML G | $50.0K | 1 |
| FUROSEMIDE INJECTION USP (10 MG/ML) 4 ML | $50.0K | 1 |
| FUROSEMIDE INJECTION USP 10 MG ML 4MLGLASS AMPOULE | $50.0K | 1 |
| FUROSEMIDE INJECTION USP(10MG/ML) 4 ML GA AIN02421 | $50.0K | 1 |
| FUROSEMIDE INJECTION USP(10MG/ML) 4ML GAAIN02421 | $42.2K | 1 |
| FUROSEMIDE INJECTION USP(10MG/ML) 4 ML GA - BATCH NO: B5H0397A |
What STERIMAX INC and other importers must comply with to import Furosemide from India
Health Canada (HC)
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
India exported $30.7M worth of Furosemide through 4,657 shipments from 333 suppliers to 150 countries, serving 778 buyers globally. STERIMAX INC imports $622.7K of this total, accounting for 1.0% of India's Furosemide exports with 14 shipments from CANADA. This is verified from 14 customs shipment records covering 12 distinct formulations.
STERIMAX INC's average Furosemide order value is $44.5K per consignment, based on 14 shipments totaling $622.7K. STERIMAX INC is based in CANADA and ranks #15 among all Furosemide importers from India by value. The company sources from 1 verified supplier in India.
STERIMAX INC sources Furosemide from 1 verified Indian supplier: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($622.7K, 100.0%). This is based on 14 customs records.
STERIMAX INC ranks #15 among 778 Furosemide importers from India with a 1.0% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ($6.3M), RISING PHARMA HOLDINGS INC ($4.2M), RISING PHARMA HOLDINGS INC,., ($3.6M). STERIMAX INC processed 14 shipments from CANADA.
STERIMAX INC imports 3 products worth $1.9M. Beyond Furosemide, top products include Ondansetron, Carmustine. View the complete STERIMAX INC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for STERIMAX INC's Furosemide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
STERIMAX INC
Full Company Profile →
3 products · $1.9M total trade · 3 categories
| $40.6K |
| 1 |
| FUROSEMIDE INJETION 10MG/ML 4ML GLASS VI | $39.8K | 1 |
STERIMAX INC imports 12 distinct Furosemide formulations from India. The top formulation is FUROSEMIDE INJECTION USP (10MG/ML) 4 ML with 2 shipments worth $100.0K.
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 778+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for STERIMAX INC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Furosemide. For current order-level data, contact TransData Nexus.